{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:22:17Z","timestamp":1787739737036,"version":"build-2784847793"},"reference-count":171,"publisher":"Impact Journals, LLC","issue":"59","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,21]]},"DOI":"10.18632\/oncotarget.19852","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T20:07:57Z","timestamp":1501790877000},"page":"100831-100851","source":"Crossref","is-referenced-by-count":47,"title":["Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment"],"prefix":"10.18632","volume":"8","author":[{"given":"Lavinia","family":"Raimondi","sequence":"first","affiliation":[{"name":"Rizzoli Orthopedic Institute, Bologna, Italy"},{"name":"Rizzoli Orthopedic Institute, Innovative Technology Platforms for Tissue Engineering, Theranostic and Oncology, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"De Luca","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Bologna, Italy"},{"name":"Rizzoli Orthopedic Institute, Innovative Technology Platforms for Tissue Engineering, Theranostic and Oncology, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Costa","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Bologna, Italy"},{"name":"Rizzoli Orthopedic Institute, Innovative Technology Platforms for Tissue Engineering, Theranostic and Oncology, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Carina","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Bologna, Italy"},{"name":"Rizzoli Orthopedic Institute, Innovative Technology Platforms for Tissue Engineering, Theranostic and Oncology, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bellavia","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Bologna, Italy"},{"name":"Rizzoli Orthopedic Institute, Innovative Technology Platforms for Tissue Engineering, Theranostic and Oncology, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pagani","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Laboratory of Preclinical and Surgical Studies, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Fini","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Laboratory of Preclinical and Surgical Studies, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Alessandro","sequence":"additional","affiliation":[{"name":"Biology and Genetics Unit, Department of Biopathology and Medical Biotechnology, University of Palermo, Palermo, Italy"},{"name":"Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giavaresi","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Innovative Technology Platforms for Tissue Engineering, Theranostic and Oncology, Palermo, Italy"},{"name":"Rizzoli Orthopedic Institute, Laboratory of Preclinical and Surgical Studies, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3322\/canjclin.16.1.26","article-title":"Osteogenic sarcoma in children","volume":"16","author":"Higinbotham","year":"1966","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4419-0284-9_2","article-title":"The etiology of osteosarcoma","volume":"152","author":"Jaffe","year":"2009","journal-title":"Cancer Treat Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/BLO.0b013e318059b8c9","article-title":"Osteosarcoma, chondrosarcoma, and Ewing\u2019s sarcoma: National Cancer Data Base Report","volume":"459","author":"Stewart","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V","article-title":"Bone cancers","volume":"75","author":"Czerniak","year":"1995","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3892\/ol.2014.1935","article-title":"Molecular mechanisms of chemoresistance in osteosarcoma (Review)","volume":"7","author":"Huang","year":"2014","journal-title":"Oncol Lett"},{"key":"6","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1200\/JCO.2004.00.5785","article-title":"Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups","volume":"23","author":"Wiebe","year":"2005","journal-title":"J Clin Oncol"},{"key":"7","first-page":"627254","article-title":"The genetics of osteosarcoma","volume":"2012","author":"Zielenska","year":"2012","journal-title":"Sarcoma"},{"key":"8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/gcc.10132","article-title":"Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas","volume":"36","author":"Squire","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/1078-0432.CCR-10-0284","article-title":"Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma","volume":"16","author":"Atkinson","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"e30907","DOI":"10.1371\/journal.pone.0030907","article-title":"Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma","volume":"7","author":"Hulsebos","year":"2012","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/gcc.10273","article-title":"High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays","volume":"38","author":"Zielenska","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ijc.10709","article-title":"Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas","volume":"102","author":"Dockhorn-Dworniczak","year":"2002","journal-title":"Int J Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/gcc.20675","article-title":"LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization","volume":"48","author":"Meza-Zepeda","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1752-1947-5-198","article-title":"Osteosarcoma in the distal femur two years after an ipsilateral femoral shaft fracture: a case report","volume":"5","author":"Jutte","year":"2011","journal-title":"J Med Case Rep"},{"key":"15","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.7314\/APJCP.2014.15.15.5967","article-title":"Review of the molecular pathogenesis of osteosarcoma","volume":"15","author":"Feng","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12079-012-0161-7","article-title":"CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis","volume":"6","author":"Siegel","year":"2012","journal-title":"J Cell Commun Signal"},{"key":"17","first-page":"301","article-title":"Advances in targeted therapy for osteosarcoma","volume":"17","author":"Yang","year":"2014","journal-title":"Discov Med"},{"key":"18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpedsurg.2005.10.024","article-title":"Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma","volume":"41","author":"LaQuaglia","year":"2006","journal-title":"J Pediatr Surg"},{"key":"19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2967\/jnumed.108.058461","article-title":"18F-FDG PET\/CT as an indicator of progression-free and overall survival in osteosarcoma","volume":"50","author":"Marom","year":"2009","journal-title":"J Nucl Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4329\/wjr.v8.i3.268","article-title":"Utility of positron emission tomography-magnetic resonance imaging in musculoskeletal imaging","volume":"8","author":"Matthews","year":"2016","journal-title":"World J Radiol"},{"key":"21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.rcl.2011.05.006","article-title":"Imaging pediatric bone sarcomas","volume":"49","author":"Kaste","year":"2011","journal-title":"Radiol Clin North Am"},{"key":"22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/pbc.26014","article-title":"Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma","volume":"63","author":"Bishop","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/pbc.21596","article-title":"Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children\u2019s Oncology Group Bone Tumor Committee","volume":"51","author":"Kailo","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diii.2015.09.013","article-title":"Accuracy of core needle biopsy for the diagnosis of osteosarcoma: A retrospective analysis of 73 patients","volume":"97","author":"Thiesse","year":"2016","journal-title":"Diagn Interv Imaging"},{"key":"25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<675::AID-CNCR13>3.0.CO;2-Y","article-title":"Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients","volume":"77","author":"Schmitz","year":"1996","journal-title":"Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Winkler","year":"2002","journal-title":"J Clin Oncol"},{"key":"27","first-page":"1123","article-title":"Osteosarcoma: a multidisciplinary approach to diagnosis and treatment","volume":"65","author":"Malawer","year":"2002","journal-title":"Am Fam Physician"},{"key":"28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pbc.24801","article-title":"Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis","volume":"61","author":"Kleinerman","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/annonc\/mdi226","article-title":"Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients","volume":"16","author":"Urban","year":"2005","journal-title":"Ann Oncol"},{"key":"30","first-page":"259817","article-title":"Corrigendum to \u201cSarcoma Immunotherapy: Past Approaches and Future Directions\u201d","volume":"2015","author":"Carvajal","year":"2015","journal-title":"Sarcoma"},{"key":"31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3892\/ol.2015.3962","article-title":"Strategies and developments of immunotherapies in osteosarcoma","volume":"11","author":"Zhang","year":"2016","journal-title":"Oncol Lett"},{"key":"32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1590\/1413-785220162403157033","article-title":"Serum Values of Alkaline Phosphatase and Lactate Dehydrogenase in Osteosarcoma","volume":"24","author":"Camargo","year":"2016","journal-title":"Acta Ortop Bras"},{"key":"33","first-page":"890","article-title":"Role of beta-isomerized C-terminal telopeptides (beta-CTx) and total procollagen type 1 amino-terminal propeptide (tP1NP) as osteosarcoma biomarkers","volume":"8","author":"Du","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1158\/0008-5472.CAN-13-2030","article-title":"Real-time liquid biopsy in cancer patients: fact or fiction?","volume":"73","author":"Alix-Panabieres","year":"2013","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00428-016-2004-z","article-title":"Pathologists and liquid biopsies: to be or not to be?","volume":"469","author":"Popper","year":"2016","journal-title":"Virchows Arch"},{"key":"36","first-page":"6504593","article-title":"MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment","volume":"2016","author":"Amodio","year":"2016","journal-title":"Biomed Res Int"},{"key":"37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/1389201015666140519104743","article-title":"MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches","volume":"15","author":"Cho","year":"2014","journal-title":"Curr Pharm Biotechnol"},{"key":"38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Hannon","year":"2004","journal-title":"Nature"},{"key":"39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1261\/rna.1399509","article-title":"Deadenylation is a widespread effect of miRNA regulation","volume":"15","author":"Izaurralde","year":"2009","journal-title":"RNA"},{"key":"40","first-page":"181","article-title":"Functional Analysis of microRNA in Multiple Myeloma","volume":"1375","author":"Tagliaferri","year":"2016","journal-title":"Methods Mol Biol"},{"key":"41","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/S1470-2045(12)70073-6","article-title":"microRNAs in cancer management","volume":"13","author":"Bushell","year":"2012","journal-title":"Lancet Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2174\/13894501113149990186","article-title":"From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario","volume":"14","author":"Tassone","year":"2013","journal-title":"Curr Drug Targets"},{"key":"43","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/0008-5472.CAN-11-2663","article-title":"miRNA signatures associate with pathogenesis and progression of osteosarcoma","volume":"72","author":"Croce","year":"2012","journal-title":"Cancer Res"},{"key":"44","first-page":"359739","article-title":"MicroRNA Involvement in Osteosarcoma","volume":"2012","author":"Duan","year":"2012","journal-title":"Sarcoma"},{"key":"45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/labinvest.2010.53","article-title":"S-MED: sarcoma microRNA expression database","volume":"90","author":"Subramanian","year":"2010","journal-title":"Lab Invest"},{"key":"46","doi-asserted-by":"crossref","first-page":"e000792","DOI":"10.1161\/JAHA.113.000792","article-title":"Circulating microRNAs: understanding the limits for quantitative measurement by real-time PCR","volume":"3","author":"Joglekar","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"47","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bone.2012.10.033","article-title":"miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis","volume":"52","author":"Lecanda","year":"2013","journal-title":"Bone"},{"key":"48","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bcp.2009.10.017","article-title":"Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1","volume":"79","author":"Shim","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.biopha.2016.10.008","article-title":"MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma","volume":"84","author":"Wang","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"50","doi-asserted-by":"crossref","first-page":"e83571","DOI":"10.1371\/journal.pone.0083571","article-title":"MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"51","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.7314\/APJCP.2013.14.6.3751","article-title":"Roles of microRNA-206 in osteosarcoma pathogenesis and progression","volume":"14","author":"Luo","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"52","first-page":"4194","article-title":"Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma","volume":"7","author":"He","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"53","first-page":"9314","article-title":"Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma","volume":"8","author":"Yuan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"54","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1186\/s40064-016-3640-0","article-title":"Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma","volume":"5","author":"Liu","year":"2016","journal-title":"Springerplus"},{"key":"55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejso.2013.08.024","article-title":"A causal role for circulating miR-34b in osteosarcoma","volume":"40","author":"Shao","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jss.2014.11.025","article-title":"Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma","volume":"194","author":"Wu","year":"2015","journal-title":"J Surg Res"},{"key":"57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jbo.2016.05.001","article-title":"miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma","volume":"5","author":"Wang","year":"2016","journal-title":"J Bone Oncol"},{"key":"58","first-page":"3765","article-title":"miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma","volume":"20","author":"Sun","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"59","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ijc.25715","article-title":"Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response","volume":"129","author":"Alberti","year":"2011","journal-title":"Int J Cancer"},{"key":"60","doi-asserted-by":"crossref","first-page":"NP105","DOI":"10.1177\/1533034615618849","article-title":"MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma","volume":"15","author":"Zhao","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jbo.2016.06.002","article-title":"Association of circulating miR-125b and survival in patients with osteosarcoma-A single center experience","volume":"5","author":"Xia","year":"2016","journal-title":"J Bone Oncol"},{"key":"62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10238-016-0422-5","article-title":"Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis","volume":"17","author":"Guo","year":"2017","journal-title":"Clin Exp Med"},{"key":"63","article-title":"New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies","volume":"17","author":"Lawrie","year":"2016","journal-title":"Int J Mol Sci"},{"key":"64","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12032-012-0340-7","article-title":"A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma","volume":"30","author":"Liu","year":"2013","journal-title":"Med Oncol"},{"key":"65","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.3390\/ijms15046544","article-title":"Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas","volume":"15","author":"He","year":"2014","journal-title":"Int J Mol Sci"},{"key":"66","doi-asserted-by":"crossref","first-page":"e0121499","DOI":"10.1371\/journal.pone.0121499","article-title":"Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"67","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1007\/s13277-015-3421-3","article-title":"Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma","volume":"36","author":"Wu","year":"2015","journal-title":"Tumour Biol"},{"key":"68","doi-asserted-by":"crossref","first-page":"e0127682","DOI":"10.1371\/journal.pone.0127682","article-title":"Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7","volume":"10","author":"Ni","year":"2015","journal-title":"PLoS One"},{"key":"69","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.3892\/ol.2016.5214","article-title":"Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma","volume":"12","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1476-4598-13-121","article-title":"miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer","volume":"13","author":"Xu","year":"2014","journal-title":"Mol Cancer"},{"key":"71","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12031-014-0230-x","article-title":"mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells","volume":"53","author":"Gao","year":"2014","journal-title":"J Mol Neurosci"},{"key":"72","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.18632\/oncotarget.3805","article-title":"miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies","volume":"6","author":"Tassone","year":"2015","journal-title":"Oncotarget"},{"key":"73","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2147\/OTT.S75899","article-title":"The role of miR-29b in cancer: regulation, function, and signaling","volume":"8","author":"Yang","year":"2015","journal-title":"Onco Targets Ther"},{"key":"74","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1074\/jbc.M809787200","article-title":"Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation","volume":"284","author":"Lian","year":"2009","journal-title":"J Biol Chem"},{"key":"75","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jcb.22243","article-title":"miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling","volume":"108","author":"Delany","year":"2009","journal-title":"J Cell Biochem"},{"key":"76","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jcp.24306","article-title":"miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease","volume":"228","author":"Giordano","year":"2013","journal-title":"J Cell Physiol"},{"key":"77","doi-asserted-by":"crossref","first-page":"e48086","DOI":"10.1371\/journal.pone.0048086","article-title":"Modulation of the osteosarcoma expression phenotype by microRNAs","volume":"7","author":"Myklebost","year":"2012","journal-title":"PLoS One"},{"key":"78","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jcp.24272","article-title":"Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness","volume":"228","author":"Russo","year":"2013","journal-title":"J Cell Physiol"},{"key":"79","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12032-014-0037-1","article-title":"Prognostic value of the microRNA-29 family in patients with primary osteosarcomas","volume":"31","author":"Zheng","year":"2014","journal-title":"Med Oncol"},{"key":"80","doi-asserted-by":"publisher","first-page":"33375","DOI":"10.18632\/oncotarget.16498","article-title":"Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma","volume":"8","author":"Kunisada","year":"2017","journal-title":"Oncotarget"},{"key":"81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2014.01.061","article-title":"miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression","volume":"444","author":"Yang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"82","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.3892\/ol.2016.5362","article-title":"Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma","volume":"12","author":"Yang","year":"2016","journal-title":"Oncol Lett"},{"key":"83","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1078-0432.CCR-15-0489","article-title":"A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells","volume":"22","author":"Anderson","year":"2016","journal-title":"Clin Cancer Res"},{"key":"84","doi-asserted-by":"crossref","first-page":"e89659","DOI":"10.1371\/journal.pone.0089659","article-title":"andactivity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells","volume":"9","author":"Tassone","year":"2014","journal-title":"PLoS One"},{"key":"85","doi-asserted-by":"crossref","first-page":"e53906","DOI":"10.1371\/journal.pone.0053906","article-title":"MicroRNA-221 induces cell survival and cisplatin resistance through PI3K\/Akt pathway in human osteosarcoma","volume":"8","author":"Fan","year":"2013","journal-title":"PLoS One"},{"key":"86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2015.07.018","article-title":"Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma","volume":"75","author":"Sun","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"87","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1074\/jbc.M109.031427","article-title":"Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells","volume":"284","author":"White","year":"2009","journal-title":"J Biol Chem"},{"key":"88","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-07-2416","article-title":"The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells","volume":"67","author":"Safe","year":"2007","journal-title":"Cancer Res"},{"key":"89","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/ijc.24530","article-title":"Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells","volume":"125","author":"Safe","year":"2009","journal-title":"Int J Cancer"},{"key":"90","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000356679","article-title":"MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells","volume":"33","author":"Ye","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"91","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biopha.2015.01.025","article-title":"Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma","volume":"71","author":"Wu","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"92","doi-asserted-by":"crossref","first-page":"34238","DOI":"10.1038\/srep34238","article-title":"MiR-24-BIM-Smac\/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci Rep"},{"key":"93","doi-asserted-by":"crossref","first-page":"19529","DOI":"10.1038\/srep19529","article-title":"Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material","volume":"6","author":"Berchem","year":"2016","journal-title":"Sci Rep"},{"key":"94","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4161\/rna.8.4.16029","article-title":"Population differences in microRNA expression and biological implications","volume":"8","author":"Dolan","year":"2011","journal-title":"RNA Biol"},{"key":"95","doi-asserted-by":"crossref","first-page":"e20769","DOI":"10.1371\/journal.pone.0020769","article-title":"Impact of cellular miRNAs on circulting miRNA biomarker signatures","volume":"6","author":"Jones","year":"2011","journal-title":"PLoS One"},{"key":"96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1423-0127-20-72","article-title":"Circulating microRNAs have a sex-specific association with metabolic syndrome","volume":"20","author":"Juo","year":"2013","journal-title":"J Biomed Sci"},{"key":"97","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/eurheartj\/eht007","article-title":"Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease","volume":"34","author":"van Zonneveld","year":"2013","journal-title":"Eur Heart J"},{"key":"98","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1160\/TH13-11-0977","article-title":"Smoking alters circulating plasma microvesicle pattern and microRNA signatures","volume":"112","author":"Assinger","year":"2014","journal-title":"Thromb Haemost"},{"key":"99","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4161\/rna.21619","article-title":"XenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles","volume":"9","author":"Witwer","year":"2012","journal-title":"RNA Biol"},{"key":"100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1534\/genetics.112.146704","article-title":"Long noncoding RNAs: past, present, and future","volume":"193","author":"Lee","year":"2013","journal-title":"Genetics"},{"key":"101","doi-asserted-by":"crossref","first-page":"C218","DOI":"10.4103\/0973-1482.145881","article-title":"Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis","volume":"10","author":"Xu","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"102","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.1038\/srep11516","article-title":"Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"103","first-page":"136106","article-title":"Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma","volume":"2013","author":"Zhou","year":"2013","journal-title":"Biomed Res Int"},{"key":"104","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","article-title":"MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer","volume":"22","author":"Serve","year":"2003","journal-title":"Oncogene"},{"key":"105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/modpathol.2012.160","article-title":"The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine","volume":"26","author":"Du","year":"2013","journal-title":"Mod Pathol"},{"key":"106","first-page":"8754","article-title":"Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63\/DXR and its parental cell line MG63 as ascertained by microarray analysis","volume":"8","author":"Zhu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"107","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2013.02.083","article-title":"Microarray expression profile of long noncoding RNAs in human osteosarcoma","volume":"433","author":"Xiao","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"108","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1007\/s13277-015-4301-6","article-title":"Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol"},{"key":"109","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.2147\/OTT.S103376","article-title":"Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients","volume":"9","author":"Mao","year":"2016","journal-title":"Onco Targets Ther"},{"key":"110","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00280-016-3029-3","article-title":"Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer","volume":"77","author":"Huang","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"111","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00280-016-2963-4","article-title":"UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy","volume":"77","author":"Tao","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"112","first-page":"498","article-title":"Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma","volume":"21","author":"Wang","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"113","first-page":"770","article-title":"Long noncoding RNA ATB promotes osteosarcoma cell proliferation, migration and invasion by suppressing miR-200s","volume":"7","author":"Zhang","year":"2017","journal-title":"Am J Cancer Res"},{"key":"114","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s13277-014-2631-4","article-title":"MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K\/Akt pathway","volume":"36","author":"Zhou","year":"2015","journal-title":"Tumour Biol"},{"key":"115","first-page":"3561","article-title":"Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma","volume":"20","author":"Lian","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"116","first-page":"46933","article-title":"MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"key":"117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-12-3422","article-title":"Biologic challenges in the detection of circulating tumor cells","volume":"73","author":"Pantel","year":"2013","journal-title":"Cancer Res"},{"key":"118","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1235226","article-title":"Cancer. Circulating tumor cells","volume":"341","author":"Werb","year":"2013","journal-title":"Science"},{"key":"119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-med-062310-094219","article-title":"Circulating tumor cells and circulating tumor DNA.","volume":"63","author":"Pantel","year":"2012","journal-title":"Annu Rev Med"},{"key":"120","first-page":"1609","article-title":"Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion","volume":"7","author":"Paterlini-Brechot","year":"2014","journal-title":"Onco Targets Ther"},{"key":"121","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/onc.2010.421","article-title":"Vimentin is a novel AKT1 target mediating motility and invasion","volume":"30","author":"Dicker","year":"2011","journal-title":"Oncogene"},{"key":"122","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Li","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"123","first-page":"2183","article-title":"Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study","volume":"6","author":"Johnson","year":"2000","journal-title":"Clin Cancer Res"},{"key":"124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s007760100046","article-title":"A PCR-ELISA assay for the detection of disseminated osteosarcoma cells in a mouse metastatic model","volume":"6","author":"Endo","year":"2001","journal-title":"J Orthop Sci"},{"key":"125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nm982","article-title":"The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis","volume":"10","author":"Helman","year":"2004","journal-title":"Nat Med"},{"key":"126","doi-asserted-by":"crossref","first-page":"S636","DOI":"10.1007\/s12032-010-9684-z","article-title":"Expression change of ezrin as a prognostic factor in primary osteosarcoma","volume":"28","author":"Huang","year":"2011","journal-title":"Med Oncol"},{"key":"127","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00428-007-0474-8","article-title":"Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas","volume":"451","author":"Bouvier","year":"2007","journal-title":"Virchows Arch"},{"key":"128","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2147\/OTT.S125589","article-title":"The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma","volume":"10","author":"Zhu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"129","article-title":"A liquid biopsy-based method for the detection and quantification of circulating tumor cells in surgical osteosarcoma patients","author":"Wu","year":"2017","journal-title":"Int J Oncol"},{"key":"130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA Comprises anNucleosome Footprint that Informs Its Tissues-Of-Origin","volume":"164","author":"Shendure","year":"2016","journal-title":"Cell"},{"key":"131","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Bardelli","year":"2014","journal-title":"J Clin Oncol"},{"key":"132","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bardelli","year":"2014","journal-title":"Sci Transl Med"},{"key":"133","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/511524a","article-title":"Cancer biomarkers: Written in blood","volume":"511","author":"Yong","year":"2014","journal-title":"Nature"},{"key":"134","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/annonc\/mdu239","article-title":"Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle","volume":"25","author":"Smolders","year":"2014","journal-title":"Ann Oncol"},{"key":"135","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2217\/fon.15.23","article-title":"EGFR mutations in lung cancer: from tissue testing to liquid biopsy","volume":"11","author":"Piccirillo","year":"2015","journal-title":"Future Oncol"},{"key":"136","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1038\/ncomms9940","article-title":"Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency","volume":"6","author":"Durr","year":"2015","journal-title":"Nat Commun"},{"key":"137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-0004.2011.01809.x","article-title":"Epigenetic modifications in cancer","volume":"81","author":"Gupta","year":"2012","journal-title":"Clin Genet"},{"key":"138","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/annonc\/mdu480","article-title":"Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?","volume":"25","author":"Dawson","year":"2014","journal-title":"Ann Oncol"},{"key":"139","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2867-7-14","article-title":"Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cellsand in xenografts: identification of apoptotic genes as targets for demethylation","volume":"7","author":"Squire","year":"2007","journal-title":"Cancer Cell Int"},{"key":"140","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1172\/JCI78437","article-title":"IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14\/NF-kappaB signaling","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"141","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3390\/ijms14035338","article-title":"Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications","volume":"14","author":"Alessandro","year":"2013","journal-title":"Int J Mol Sci"},{"key":"142","doi-asserted-by":"publisher","first-page":"13772","DOI":"10.18632\/oncotarget.3830","article-title":"Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation","volume":"6","author":"Tassone","year":"2015","journal-title":"Oncotarget"},{"key":"143","doi-asserted-by":"crossref","first-page":"e5219","DOI":"10.1371\/journal.pone.0005219","article-title":"High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients","volume":"4","author":"Lozupone","year":"2009","journal-title":"PLoS One"},{"key":"144","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ejca.2013.01.017","article-title":"Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells","volume":"49","author":"O\u2019Driscoll","year":"2013","journal-title":"Eur J Cancer"},{"key":"145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","article-title":"Exosomes in tumor microenvironment influence cancer progression and metastasis","volume":"91","author":"Kalluri","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"146","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.acc.2015.12.005","article-title":"Tumor-Derived Exosomes and Their Role in Cancer Progression","volume":"74","author":"Whiteside","year":"2016","journal-title":"Adv Clin Chem"},{"key":"147","doi-asserted-by":"crossref","first-page":"27522","DOI":"10.3402\/jev.v4.27522","article-title":"Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis","volume":"4","author":"Zheng","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"148","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2015.02.019","article-title":"Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes","volume":"87","author":"Shah","year":"2015","journal-title":"Methods"},{"key":"149","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1007\/s10853-017-0905-0","article-title":"Silica nanostructured platform for affinity capture of tumor-derived exosomes","volume":"52","author":"Norton","year":"2017","journal-title":"Journal of Materials Science"},{"key":"150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cca.2015.12.031","article-title":"Circulating melanoma exosomes as diagnostic and prognosis biomarkers","volume":"454","author":"Gonzalez","year":"2016","journal-title":"Clin Chim Acta"},{"key":"151","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Fraga","year":"2015","journal-title":"Nature"},{"key":"152","doi-asserted-by":"publisher","first-page":"13048","DOI":"10.18632\/oncotarget.14369","article-title":"Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"153","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jcb.25642","article-title":"Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media From Human Osteosarcoma Cell Lines Reveals Secretion of Proteins Related to Tumor Progression","volume":"118","author":"Galindo","year":"2017","journal-title":"J Cell Biochem"},{"key":"154","article-title":"Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression","author":"Dominici","year":"2017","journal-title":"Clin Cancer Res"},{"key":"155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ijo.2016.3509","article-title":"Multimodal transfer of MDR by exosomes in human osteosarcoma","volume":"49","author":"Baldini","year":"2016","journal-title":"Int J Oncol"},{"key":"156","doi-asserted-by":"publisher","first-page":"75968","DOI":"10.18632\/oncotarget.18373","article-title":"Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"},{"key":"157","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1741-7015-10-87","article-title":"The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?","volume":"10","author":"Diamandis","year":"2012","journal-title":"BMC Med"},{"key":"158","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1878-5085-4-7","article-title":"Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine","volume":"4","author":"Krapfenbauer","year":"2013","journal-title":"EPMA J"},{"key":"159","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Fraumeni","year":"1969","journal-title":"Ann Intern Med"},{"key":"160","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Tainsky","year":"1990","journal-title":"Science"},{"key":"161","first-page":"6643","article-title":"Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype","volume":"63","author":"Eeles","year":"2003","journal-title":"Cancer Res"},{"key":"162","first-page":"3042","article-title":"Mutation spectrum of the retinoblastoma gene in osteosarcomas","volume":"54","author":"Yamamuro","year":"1994","journal-title":"Cancer Res"},{"key":"163","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1200\/JCO.2006.08.4558","article-title":"Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome","volume":"25","author":"Wang","year":"2007","journal-title":"J Clin Oncol"},{"key":"164","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z","article-title":"Rothmund-Thomson syndrome due to RECQ4 helicase mutations: report and clinical and molecular comparisons with Bloom syndrome and Werner syndrome","volume":"90","author":"Jalal","year":"2000","journal-title":"Am J Med Genet"},{"key":"165","volume-title":"GeneReviews(R)","author":"Stephens","year":"1993"},{"key":"166","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13577140410001679266","article-title":"Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy","volume":"8","author":"Briggs","year":"2004","journal-title":"Sarcoma"},{"key":"167","doi-asserted-by":"crossref","first-page":"P58","DOI":"10.1359\/jbmr.06s211","article-title":"Osteosarcoma in Paget\u2019s disease of bone","volume":"21","author":"Merchant","year":"2006","journal-title":"J Bone Miner Res"},{"key":"168","first-page":"808","article-title":"Radiation-induced sarcomas of bone: factors that affect outcome","volume":"89","author":"Abudu","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"169","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<370::AID-IJC11>3.0.CO;2-C","article-title":"Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood","volume":"77","author":"Lagrange","year":"1998","journal-title":"Int J Cancer"},{"key":"170","first-page":"106","article-title":"A system for the surgical staging of musculoskeletal sarcoma","author":"Goodman","year":"1980","journal-title":"Clin Orthop Relat Res"},{"key":"171","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.3892\/etm.2016.3838","article-title":"Downregulation of microRNA-497 is associated with upregulation of synuclein gamma in patients with osteosarcoma","volume":"12","author":"Gong","year":"2016","journal-title":"Exp Ther Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T19:44:14Z","timestamp":1659296654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":171,"journal-issue":{"issue":"59","published-print":{"date-parts":[[2017,11,21]]}},"alternative-id":["19852","29246026"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19852","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}